Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

NCT00053378 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00053378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Double-Blind Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2002
Completion date
Not reported
Enrollment
45
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hypocalcemia